Open AccessGENERALIZED URTICARIA AS A VASCULITIC MANIFESTATION IN A PATIENT WITH SARS-CoV-2 INFECTION: A CASE REPORT IN COLOMBIA
Author(s) -
D. Sepúlveda-Beltran,
Álvaro Mondragón-Cardona,
C. E. Conde-Martin,
O. A. Lopez-Guevara,
N. R. Hernandez-Rojas,
Mario Alberto Caviedes-Cleves,
D. E. Gutierrez-Ortega,
C. R. Rangel-Meza,
F. K. Conde-Tavera,
Alfonso J. Rodríguez-Morales,
Kuldeep Dhama
Publication year - 2021
Publication title -
journal of experimental biology and agricultural sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.108
H-Index - 2
ISSN - 2320-8694
DOI - 10.18006/2021.9(2).131.137
Subject(s) - medicine , rash , dermatology , erythema , vasculitis , immunology , thrombosis , immune dysregulation , immune system , pathology , disease
Skin manifestations have been reported in up to 20% of cases of SARS-CoV-2 infection, including morbilliform rash (22%), pernio-like acral lesions (18%), urticaria (16%), and macular erythema (13%). It is believed that in the case of SARS-CoV-2 infection, the mechanism involved is an inflammatory response that generates immune dysregulation, vascular congestion, vasculitis, vascular thrombosis, or neoangiogenesis. This case study, present the case of a patient with no previous history of urticarial reactions, autoimmune diseases, or exposure to medications who develops generalized urticaria lasting more than 24 hours and who was diagnosed with SARS-CoV-2 infection by RT-PCR with a nasopharyngeal swab. We suggest in this patient vasculitic urticaria as a manifestation of SARS-CoV-2 infection.